Unity Biotechnology (UBX) News Today → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free UBX Stock Alerts $1.42 -0.06 (-4.05%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 5:12 AM | americanbankingnews.comHC Wainwright Reaffirms "Buy" Rating for Unity Biotechnology (NASDAQ:UBX)May 17 at 6:52 AM | americanbankingnews.comUnity Biotechnology, Inc. (NASDAQ:UBX) to Post Q2 2024 Earnings of ($0.44) Per Share, HC Wainwright ForecastsMay 16, 2024 | markets.businessinsider.comBuy Rating on Unity Biotechnology: Promising Future for UBX1325 in Diabetic Macular Edema TreatmentMay 15, 2024 | investorplace.comUBX Stock Earnings: Unity Biotechnology Beats EPS for Q1 2024May 14, 2024 | globenewswire.comUNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business UpdatesApril 25, 2024 | globenewswire.comUNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual MeetingApril 23, 2024 | globenewswire.comUNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DMEApril 15, 2024 | investorplace.comUBX Stock Earnings: Unity Biotechnology Beats EPS for Q4 2023April 15, 2024 | globenewswire.comUNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business UpdatesApril 9, 2024 | finance.yahoo.comUnity Biotechnology, Inc. (0YC0.L)February 17, 2024 | finance.yahoo.comUBX Mar 2024 2.000 callFebruary 7, 2024 | uk.investing.comUnity Biotechnology Inc (UBX)February 6, 2024 | finance.yahoo.comNew Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision LossDecember 29, 2023 | finance.yahoo.com10 Supplements for Longevity and Antiaging: Expert RecommendationsDecember 12, 2023 | finance.yahoo.comUNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DMENovember 27, 2023 | msn.comUnity Biotechnology (UBX) Price Target Increased by 8.33% to 6.63November 17, 2023 | msn.comWedbush Upgrades Unity Biotechnology (UBX)November 16, 2023 | msn.comWedbush upgrades Unity Biotechnology to outperform, cites cash runwayNovember 16, 2023 | finance.yahoo.comCompanies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite RiskyNovember 15, 2023 | markets.businessinsider.comUnity Biotechnology’s Promising Senolytic Therapy UBX1325 and Financial Stability Bolsters Buy RatingNovember 14, 2023 | finanznachrichten.deUnity Biotechnology, Inc.: UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business UpdatesNovember 14, 2023 | msn.comUnity Biotechnology GAAP EPS of -$1.05 misses by $0.16November 13, 2023 | tmcnet.comUNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business UpdatesNovember 13, 2023 | finance.yahoo.comUNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business UpdatesNovember 10, 2023 | msn.comUNITY Biotechnology to exercise warrants for $4.38M in gross proceedsNovember 10, 2023 | finance.yahoo.comUNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross ProceedsOctober 25, 2023 | finance.yahoo.comAre Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging PicksOctober 3, 2023 | finance.yahoo.com20 Foods Consumed By Longest Living People Every DaySeptember 28, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Unity Biotechnology (UBX) and Rockwell Med (RMTI)September 27, 2023 | markets.businessinsider.comUNITY Biotechnology Reports Encouraging Results From Phase 2 ENVISION Study Of UBX1325September 27, 2023 | finance.yahoo.comUNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular DegenerationSeptember 16, 2023 | finance.yahoo.comUnity Biotechnology Inc CEO Anirvan Ghosh Sells 1,246 SharesAugust 15, 2023 | finance.yahoo.com20 States With The Longest Life Expectancy In AmericaAugust 9, 2023 | markets.businessinsider.comAnalyst Ratings for Unity BiotechnologyAugust 8, 2023 | finance.yahoo.comUNITY Biotechnology, Inc. Reports Second Quarter 2023 Financial Results and Business UpdatesJuly 9, 2023 | nasdaq.comUnity Biotechnology, Inc. Common Stock (UBX)June 27, 2023 | benzinga.comDirector at Unity Biotechnology Acquires Company Stock Options Worth 6,000 SharesJune 27, 2023 | benzinga.comUnity Biotechnology Board Member Awarded $16K Worth of Stock OptionsJune 26, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Unity BiotechnologyJune 21, 2023 | finance.yahoo.comUNITY Announces Design of Phase 2b ASPIRE Study Evaluating UBX1325 in Diabetic Macular Edema (DME)May 15, 2023 | markets.businessinsider.comWedbush Sticks to Its Buy Rating for Unity Biotechnology (UBX)May 10, 2023 | msn.comHC Wainwright & Co. Reiterates Unity Biotechnology (UBX) Buy RecommendationMay 10, 2023 | markets.businessinsider.comUnity Biotechnology (UBX) Gets a Buy from H.C. WainwrightMay 9, 2023 | yahoo.comUNITY Biotechnology, Inc. Reports First Quarter 2023 Financial Results and Business UpdatesMay 9, 2023 | finance.yahoo.comUNITY Biotechnology, Inc. Reports First Quarter 2023 Financial Results and Business UpdatesApril 25, 2023 | markets.businessinsider.comWhere Unity Biotechnology Stands With AnalystsApril 25, 2023 | markets.businessinsider.comUnity Biotechnology (UBX) Gets a Buy from WedbushApril 25, 2023 | msn.comWedbush Maintains Unity Biotechnology (UBX) Outperform RecommendationApril 24, 2023 | markets.businessinsider.comUnity Biotechnology (UBX) Receives a Rating Update from a Top AnalystApril 24, 2023 | finance.yahoo.comUnity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eylea Get Unity Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for UBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. UBX Media Mentions By Week UBX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UBX News Sentiment▼0.830.42▲Average Medical News Sentiment UBX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UBX Articles This Week▼100▲UBX Articles Average Week Get Unity Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for UBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Oncternal Therapeutics News Today Acasti Pharma News Today Biora Therapeutics News Today JanOne News Today NanoViricides News Today Iterum Therapeutics News Today Forte Biosciences News Today Lisata Therapeutics News Today RenovoRx News Today Enlivex Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UBX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profits4 Cryptos BETTER than BitcoinTrue Market InsidersNext President (Not Trump. Not Biden.)The Freeport SocietyThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unity Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
